Study guide

6.4 Cutaneous Malignancies & Blistering Disorders

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

6.4 Cutaneous Malignancies & Blistering Disorders

Key Takeaways Explain This Topic AI

Basal cell carcinoma is the most common skin cancer (~80%), featuring pearly translucent papules with telangiectasias and basaloid nests with peripheral palisading; it exhibits extremely low metastatic potential (< 0.1%) but causes local tissue destruction.

Breslow depth (vertical thickness in mm) is the single most crucial prognostic indicator for localized cutaneous melanoma; full-thickness excisional biopsy with 1-3 mm margins is mandatory, while shave biopsies are contraindicated.

Pemphigus vulgaris features anti-desmoglein-3 autoantibodies, flaccid intraepidermal bullae, positive Nikolsky sign, net-like IgG DIF pattern, and early oral mucosal ulceration (> 80% of cases), requiring high-dose systemic steroids and rituximab.

Bullous pemphigoid features anti-hemidesmosomal (BP180/BP230) autoantibodies, tense subepidermal bullae, negative Nikolsky sign, linear IgG/C3 basement membrane DIF pattern, and sparing of mucous membranes in elderly patients (> 60 years).

Toxic Epidermal Necrolysis (TEN) involves full-thickness epidermal detachment > 30% BSA (SJS < 10% BSA) triggered by high-risk drugs (allopurinol, lamotrigine, TMP-SMX), requiring immediate drug cessation and transfer to an ICU or burn unit.

Last updated: July 2026

Cutaneous Malignancies & Blistering Disorders

Prompt diagnosis of cutaneous neoplasms and blistering eruptions requires integrating clinical morphology, microscopic architecture, immunofluorescent patterns, and staging criteria. Recognizing high-risk malignancies and severe cutaneous adverse reactions prevents life-threatening complications.

Non-Melanoma Cutaneous Malignancies & Precursors

Basal Cell Carcinoma (BCC) is the most common cutaneous malignancy in humans (~80% of skin cancers):

Clinical Presentation : Classically appears on sun-exposed head and neck areas as a pearly, translucent papule or nodule with prominent overlying telangiectasias , rolled borders, and central ulceration ("rodent ulcer").

Histopathology : Demonstrates nests of basaloid keratinocytes extending from the epidermis into the dermis with characteristic peripheral palisading of nuclei and specialized stromal retraction artifact.

Behavior & Management : BCC exhibits extremely low metastatic potential (< 0.1%) , but is locally invasive and destructive. Diagnosis is established via punch or excisional biopsy. Definitive treatment involves surgical excision with 3 to 5 mm margins. Mohs micrographic surgery (intraoperative complete margin assessment) is indicated for lesions located in high-risk anatomic zones (facial regions, nose, eyelids, ears), recurrent tumors, or aggressive histologic subtypes.

Squamous Cell Carcinoma (SCC) is the second most common skin cancer (~20%):

Clinical Presentation : Presents as an indurated, erythematous, scaly plaque or nodule, often with central ulceration or hyperkeratotic crusting on sun-exposed areas (lower lip, ears, dorsum of hands).

Precursor Lesions : Actinic Keratosis (AK) represents a premalignant lesion caused by UV radiation damage, presenting as rough, red, "sandpaper-like" papules. Un-treated AKs progress to invasive SCC at a rate of 0.1% to 1% per year. AKs are treated with cryotherapy, topical 5-fluorouracil, or imiquimod. Marjolin ulcer refers to an aggressive form of SCC arising within chronic non-healing burn scars or sinus tracts.

Histopathology : Demonstrates atypical keratinocytes invading the dermis with keratin pearls and intercellular bridges.

Behavior & Management : SCC possesses moderate metastatic risk (2% to 5%, higher for lip and ear lesions). Surgical excision with 4 to 6 mm margins or Mohs surgery is curative.

Melanoma Pathophysiology & Biopsy Protocols

Cutaneous Melanoma is the most lethal skin malignancy, arising from transformed melanocytes:

ABCDE Criteria : A symmetry, B order irregularity, C olor variation (variegated black, brown, red, blue), D iameter >= 6 mm, and E volution/Enlargement over time.

Subtypes : Superficial spreading (70% of cases, prominent radial growth phase), Nodular (early vertical growth phase, aggressive), Lentigo maligna (elderly sun-damaged facial skin), and Acral lentiginous (occurs on palms, soles, and subungual sites; most common subtype in dark-skinned individuals , unrelated to UV light exposure).

Prognostic Determination : Breslow depth (measured in millimeters from the stratum granulosum to the deepest tumor cell) is the single most important prognostic factor for localized melanoma.

Biopsy Protocol : Full-thickness excisional biopsy with 1 to 3 mm narrow margins is mandatory for suspicious pigmented lesions. Shave biopsies are strictly contraindicated because partial transection invalidates accurate Breslow depth measurement and tumor staging.

Staging & Surgical Margins : Sentinel lymph node biopsy (SLNB) is indicated for melanomas with Breslow depth > 0.8 mm (or < 0.8 mm with ulceration or high mitotic rate). Wide local excision margin guidelines are based on Breslow depth: Melanoma in situ = 0.5 cm margin; thickness <= 1.0 mm = 1.0 cm margin; 1.01 to 2.0 mm = 1.0 to 2.0 cm margin; > 2.0 mm = 2.0 cm margin. Metastatic melanoma is tested for BRAF V600E mutations (treated with targeted BRAF/MEK inhibitors, e.g., dabrafenib + trametinib) and immune checkpoint inhibitors (anti-PD-1 pembrolizumab).

Autoimmune Blistering Disorders

Autoimmune blistering diseases are defined by target autoantigens and anatomical level of skin cleavage:

Pemphigus Vulgaris (PV) : Autoimmune disease caused by IgG autoantibodies targeting Desmoglein-3 (and Desmoglein-1), components of desmosomes mediating cell-to-cell adhesion in the epidermis.

Clinical Presentation : Flaccid, painful bullae that rupture easily, leaving extensive raw, denuded erosions. Positive Nikolsky sign (gentle lateral pressure on normal-appearing skin causes epidermal detachment). Mucous membrane involvement (painful oral ulcers) occurs first in > 80% of patients .

Histopathology & DIF : Shows acantholysis (loss of keratinocyte adhesion) producing intraepidermal bullae with a row of basal cells attached to the basement membrane ("tombstoning"). Direct Immunofluorescence (DIF) reveals a classic "net-like" or "chicken-wire" pattern of IgG and C3 throughout the epidermal intercellular space.

Management : High-dose systemic oral corticosteroids (prednisone 1 mg/kg/day) combined with rituximab (anti-CD20 monoclonal antibody).

Bullous Pemphigoid (BP) : Autoimmune disease in elderly patients (> 60 years) caused by IgG autoantibodies against hemidesmosomal antigens ( BP180 and BP230 ) at the dermal-epidermal junction.

Clinical Presentation : Large, tense, firm bullae on normal or erythematous skin. Bullae resist rupture. Negative Nikolsky sign . Intensely pruritic urticarial prodrome. Mucous membranes are characteristically spared (or mildly involved in < 20%).

Histopathology & DIF : Shows subepidermal bullae filled with eosinophils. DIF demonstrates a continuous linear band of IgG and C3 along the basement membrane zone .

Management : High-potency topical corticosteroids ( clobetasol propionate cream ) for localized disease; oral corticosteroids plus azathioprine or mycophenolate for severe cases.

Dermatitis Herpetiformis (DH) : Autoimmune cutaneous manifestation of Celiac Disease driven by IgA autoantibodies against epidermal transglutaminase . Presents with intensely pruritic, grouped papules and small vesicles symmetrically distributed over extensor surfaces (elbows, knees, buttocks). DIF shows granular IgA deposits within dermal papillae . Treatment requires a strict gluten-free diet and oral dapsone (provides rapid symptomatic relief within 24-48 hours; mandatory G6PD deficiency screening prior to dapsone initiation to prevent severe hemolytic anemia).

Severe Cutaneous Adverse Reactions (SJS / TEN)

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) represent life-threatening drug-induced hypersensitivity reactions marked by widespread keratinocyte apoptosis and full-thickness epidermal necrosis. High-risk offending drugs include allopurinol , antiepileptics ( carbamazepine , phenytoin , lamotrigine ), sulfonamides (TMP-SMX), and NSAIDs.

Clinical Presentation : Begins 1 to 3 weeks post-drug exposure with a prodrome of fever, malaise, and upper respiratory symptoms, followed by painful dusky erythematous macules, targetoid lesions, flaccid bullae, and a positive Nikolsky sign . Multi-mucosal involvement (oral, ocular, and urogenital erosions) occurs in > 90% of cases.

BSA Classification : Categorized by percentage of total body surface area exhibiting epidermal detachment:

SJS : < 10% BSA detachment.

SJS/TEN Overlap : 10% to 30% BSA detachment.

TEN : > 30% BSA detachment.

Management Protocol : Immediate discontinuation of the offending drug is the single most critical intervention. Patients mandate immediate transfer to an Intensive Care Unit (ICU) or Burn Center . Supportive care includes aggressive fluid replacement, sterile wound care, nutritional support, and mandatory urgent ophthalmology consultation to prevent cicatrizing conjunctivitis, corneal ulceration, and permanent blindness.

  • Diagnostic Algorithm: Pigmented Lesion Evaluation & Staging [ Suspicious Pigmented Cutaneous Lesion ]
  • │
  • ├─► Apply ABCDE Criteria (Asymmetry, Border, Color, Diameter >= 6mm, Evolution)
  • │
  • ▼
  • [ Full-Thickness Excisional Biopsy ] (1-3 mm margins; NO SHAVE BIOPSY!)
  • │
  • ▼
  • [ Histopathologic Evaluation ]
  • │
  • ┌───────────┴───────────┐
  • ▼ ▼
  • [ Breslow Depth <= 0.8 mm ] [ Breslow Depth > 0.8 mm ]
  • │ │
  • ├─► Wide Local Excision ├─► Sentinel Lymph Node Biopsy (SLNB)
  • │ (1 cm margin) ├─► Wide Local Excision (1-2 cm margin)
  • │ └─► BRAF V600E Mutation Testing (if metastatic)
  • ▼ ▼
  • [ Routine Follow-up ] [ Targeted / Immunotherapy ]
  • Comparative Matrix of Autoimmune & Drug-Induced Blistering Disorders

Disease Entity Target Autoantigen / Etiology Cleavage Level Nikolsky Sign Mucosal Involvement Direct Immunofluorescence Pattern

Pemphigus Vulgaris Desmoglein-3 (Desmosomes) Intraepidermal (Acantholysis) Positive Present early (> 80%) Net-like / Chicken-wire IgG/C3 in epidermis

Bullous Pemphigoid BP180 / BP230 (Hemidesmosomes) Subepidermal Negative Typically Spared (< 20%) Linear band of IgG/C3 along basement membrane

Dermatitis Herpetiformis Epidermal Transglutaminase Subepidermal (Dermal papillae) Negative Absent Granular IgA in dermal papillae

SJS / TEN Drug-induced Keratinocyte Apoptosis Full-thickness Epidermis Positive Severe Multi-mucosal (> 90%) Negative for autoimmune antibodies; full epidermal necrosis